Aardvark Therapeutics, Inc.
AARD · NASDAQ · USD
$4.76
+0.05 1.06%todayNot financial advice.
- Open
- 4.61
- Day range
- 4.60 - 4.82
- 52-week range
- 3.35 - 16.60
- Volume
- 140.86K
- Market cap
- 104.17M
- P/E ratio
- —
- EPS
- -3.21
- Dividend yield
- 0.00%
- Beta
- 3.61
Performance
W
−11.36%
1M
−10.69%
3M
−5.37%
6M
+21.43%
YTD
−64.21%
Y
−72.00%
5Y
−68.64%
All
−68.64%
In the news
Oct 8
Aardvark Therapeutics Names Regulatory Expert David Zhang to Board
Aardvark Therapeutics appointed regulatory expert David Zhang to its board as its lead drug candidate ARD-101 faces an FDA clinical hold.
Company news
Oct 8
Aardvark Therapeutics Appoints David Zhang to Board of Directors
Aardvark Therapeutics has appointed clinical development veteran David Zhang to its board to help guide ARD-101 through regulatory pathways.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-AARD" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Aardvark Therapeutics, Inc. (AARD) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-AARD">AARD stock price</a> by FreeTheAI Stocks</p>